
Doximity (NYSE: DOCS): Growth is Malignant, Not Benign
Opinion: Strong Sell. I am short DOCS. I believe DOCS is not "LinkedIn for Doctors" but "ZoomInfo Targeting Doctors" and it is a predatory business model set to burst in 2025. Doximity AKA "LinkedIn for Doctors" is a business in declining health with major